Cardiology
What they do most for Medicare patients
| Service, sort | Times billed, sort |
|---|---|
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 7,133,394 |
| Established patient office or other outpatient visit, 30-39 minutes | 7,103,722 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 4,662,642 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 4,628,653 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 1,765,274 |
| Established patient office or other outpatient visit, 20-29 minutes | 1,559,437 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 1,107,913 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 827,894 |
| Established patient office or other outpatient visit, 40-54 minutes | 792,949 |
| New patient office or other outpatient visit, 45-59 minutes | 695,579 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 616,724 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 598,516 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 536,418 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 504,120 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 465,020 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 444,008 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 419,558 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 416,842 |
| Ultrasound of both sides of head and neck blood flow | 412,352 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 386,471 |
| Insertion of needle into vein for collection of blood sample | 376,864 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 359,314 |
| Anticoagulant management of patient taking warfarin | 347,182 |
| Blood test, clotting time | 326,290 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 317,727 |
| Ultrasound of heart, follow-up | 304,776 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 299,739 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 288,755 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 286,735 |
| Heart muscle strain imaging | 265,661 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 264,750 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 244,564 |
| Programming of dual lead pacemaker system | 227,895 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 221,662 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 209,478 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 179,477 |
| Ultrasound of heart blood flow, valves and chambers | 170,680 |
| Ultrasound of heart with probe in esophagus, with report | 157,689 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 152,831 |
| New patient office or other outpatient visit, 60-74 minutes | 149,191 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 148,120 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 133,888 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 132,538 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 130,298 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 123,208 |
| Critical care, first 30-74 minutes | 116,464 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 114,363 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 112,067 |
| Blood test, lipids (cholesterol and triglycerides) | 107,822 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 107,193 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 106,047 |
| Ultrasound of leg arteries or artery grafts | 94,964 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 93,612 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 87,144 |
| Blood test, comprehensive group of blood chemicals | 84,872 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 82,323 |
| New patient office or other outpatient visit, 30-44 minutes | 82,033 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 76,849 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 74,657 |
| Established patient office or other outpatient visit, 10-19 minutes | 69,324 |
| External shock to heart to regulate heart beat | 68,130 |
| Nuclear medicine study of heart muscle blood flow by pet | 62,556 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 59,913 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 59,868 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 59,757 |
| Heart rhythm recording of continous external ekg over 8-15 days | 59,112 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 57,520 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 55,706 |
| 3d radiographic procedure | 55,656 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 55,284 |
| Ct scan of blood vessels and grafts of heart with contrast | 52,577 |
| Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | 52,559 |
| Ultrasound study of arm and leg arteries | 51,736 |
| Blood test, thyroid stimulating hormone (tsh) | 51,139 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 49,318 |
| Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services | 49,195 |
| Intensive cardiac rehabilitation; with or without continuous ecg monitoring with exercise, per session | 47,858 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 46,590 |
| Blood test, basic group of blood chemicals (calcium, total) | 44,951 |
| Telephone medical discussion with physician, 11-20 minutes | 39,855 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | 38,209 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 36,442 |
| Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | 34,528 |
| Complete ultrasound study of arm and leg arteries | 34,329 |
| Hemoglobin a1c level | 34,241 |
| Hospital discharge day management, 30 minutes or less | 32,208 |
| Intensive cardiac rehabilitation; with or without continuous ecg monitoring; without exercise, per session | 31,958 |
| Natriuretic peptide (heart and blood vessel protein) level | 31,758 |
| Magnesium level | 31,684 |
| Hospital discharge day management, more than 30 minutes | 30,978 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 29,950 |
| Programming of multiple lead implantable defibrillator system | 29,829 |
| Telephone medical discussion with physician, 21-30 minutes | 29,365 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 29,251 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) | 29,157 |
| Test for allergy using allergenic extract | 28,776 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 24,680 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 24,307 |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 23,938 |
| Programming of dual lead implantable defibrillator system | 23,666 |
Sources: Medicare Care Compare (hospitals and schools; Medicare-enrolled clinicians), CMS Medicare Physician & Other Practitioners 2023 (services), Medicare Part D Prescribers 2024 (drugs).